CION Ameerpet
Hyderabad's Cervical Cancer Care Team
Cervical Cancer Treatment in Hyderabad — Expert Care Across 7 Locations
Cervical cancer is the second most common cancer in Indian women — and one of the most preventable and, when caught early, one of the most curable cancers in all of oncology. At CION Cancer Clinics, our gynaecologic oncology team delivers expert cervical cancer care — from fertility-sparing surgery for young women with early disease to brachytherapy-based treatment and the latest immunotherapy for advanced cases — across 7 Hyderabad locations, backed by 5-Star NABH accreditation and evidence-based treatment protocols.
- Fertility-Sparing Trachelectomy — for young women with early-stage disease who want to preserve the ability to have children
- Image-Guided Brachytherapy — internal radiation essential for curing locally advanced cervical cancer
- HPV Vaccination Programme — Gardasil 9 for prevention from age 9 onwards
- Tumour Board for Every Patient — surgical, radiation & medical oncology together before any treatment plan
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Did You Know? Cervical cancer is almost entirely preventable. HPV vaccination before exposure to the virus eliminates the risk from the two types of HPV responsible for approximately 70% of all cervical cancers. Regular Pap smear and HPV DNA screening catches dangerous cell changes years before they become cancer. No other major cancer offers this level of preventability — yet India accounts for about 25% of global cervical cancer deaths.
What Is Cervical Cancer?
The cervix is the lower, narrow part of the uterus — the passage between the womb and the vagina. Cervical cancer develops when cells in the cervix lining start to grow abnormally. The change from normal cells to cancer is usually a slow process, typically taking 10 to 15 years. This long pre-cancerous phase is what makes cervical cancer uniquely detectable and preventable through screening.
There are two main types based on which cells are involved:
70–80% of cases
Squamous Cell Carcinoma
Develops in the flat, skin-like cells that cover the outer surface of the cervix. The most common type — and the one most readily detected by Pap smear screening because it arises on the visible surface of the cervix.
20–25% of cases
Adenocarcinoma
Develops in the column-shaped cells that line the inner cervical canal. Slightly harder to detect by Pap smear as it arises higher up in the cervical canal — which is why combining Pap smear with HPV DNA testing (co-testing) improves screening sensitivity.
HPV — Why Almost All Cervical Cancers Are Preventable
Human papillomavirus (HPV) is a very common virus transmitted through skin-to-skin contact, including sexual contact. In most people, the immune system clears HPV within 1 to 2 years without any lasting effects. In some women, however, certain high-risk types of HPV persist and over many years cause the cell changes in the cervix that eventually develop into cancer.
Two HPV types — HPV-16 and HPV-18 — together cause approximately 70% of all cervical cancers. HPV vaccination protects specifically against these types, and when given before HPV exposure (ideally to girls and boys aged 9 to 14), it dramatically reduces the lifetime risk of cervical cancer.
HPV Vaccination — India Context and Recommendation
India's national HPV vaccination programme recommends the vaccine for girls aged 9 to 14 as part of the school immunisation schedule. Older girls and young women up to age 26 (and in some circumstances up to 45) also benefit, particularly if they have not yet been exposed to HPV. The vaccine does not treat existing HPV infection — it prevents future infection with the types it covers. Two doses are needed for those vaccinated before age 15; three doses for older age groups. Ask your doctor or CION's team about HPV vaccination for yourself, your daughters, or your family.
Cervical Cancer Screening — The Single Most Effective Prevention Tool
Because cervical cancer has a long pre-cancerous phase, regular screening can detect cell changes years before they become invasive cancer — at a stage when treatment is simple and outcomes are excellent.
Every 3 years from age 21
Pap Smear (Papanicolaou Test)
A sample of cells is gently collected from the cervix during a routine examination and examined under a microscope for abnormal changes. The foundation of cervical screening for over 50 years.
Every 5 years from age 30
HPV DNA Test
A test of cervical cells that detects the presence of high-risk HPV types. More sensitive than Pap smear alone — can be combined with Pap smear (co-testing) for the most accurate screening.
Community / rural settings
VIA (Visual Inspection with Acetic Acid)
A simpler screening method where dilute acetic acid (vinegar) is applied to the cervix and precancerous areas turn white. Widely used across rural India as an accessible alternative to laboratory-based testing — provides immediate results.
If your Pap smear or HPV test returns an abnormal result, this does not automatically mean you have cancer. Abnormal cells go through several stages before becoming cancer — and CION's gynaecologic oncology team can evaluate and manage these changes before they progress.
Risk Factors for Cervical Cancer
- HPV infection — the primary cause; almost all cervical cancers are linked to high-risk HPV types
- Not having been vaccinated against HPV
- No regular Pap smear or HPV screening — the majority of cervical cancers in India are diagnosed in women who have never had a cervical screening
- Smoking — women who smoke are more vulnerable to HPV infection and have reduced immune response to clearing it
- Weakened immune system — women with HIV, or those taking medicines that suppress the immune system after organ transplant, are at significantly higher risk
- Early first sexual contact — increases the duration of potential HPV exposure
- Multiple sexual partners — increases the likelihood of HPV exposure
Symptoms of Cervical Cancer
Early cervical cancer often has no symptoms at all — which is why screening is so important. When symptoms do appear, they may include:
- Abnormal vaginal bleeding — bleeding after sex, bleeding between periods, or vaginal bleeding after menopause; the most common symptom
- Unusual vaginal discharge — watery, bloody, or with an unusual odour
- Pelvic pain or pain during sexual intercourse
- Pain or discomfort in the lower back or legs (more advanced disease)
- Painful or more frequent urination
- Unexplained weight loss, tiredness, and loss of appetite in advanced disease
Any unusual vaginal bleeding — especially bleeding after sex, between periods, or after menopause — should be evaluated by a gynaecologist or oncologist. Do not wait for additional symptoms to develop.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Every Cervical Cancer Case, Reviewed by Our Tumour Board
Surgical, radiation, and medical oncology together — before any treatment plan is finalised. 45-minute consultations. No rushed decisions.
Diagnosing Cervical Cancer at CION
Colposcopy and Biopsy
If a Pap smear or HPV test is abnormal, or if symptoms suggest cervical cancer, a colposcopy is performed. The doctor uses a specialised magnifying device (colposcope) to examine the cervix closely under bright light. Any suspicious area is biopsied — a small tissue sample is taken and sent to the laboratory to confirm whether cancer is present and identify the exact type.
Staging Investigations
- MRI Pelvis — the most important staging scan; shows tumour size, depth of invasion, involvement of nearby structures (bladder, rectum, parametrium), and lymph node status
- CT Scan (chest, abdomen, pelvis) — checks whether cancer has spread to distant lymph nodes or organs
- PET-CT — for detecting lymph node spread and distant metastases that may not be visible on CT
- Cystoscopy / Rectoscopy — if bladder or bowel involvement is suspected, a camera examination confirms this
Cervical Cancer Staging and Survival Rates
Cervical cancer is staged using the FIGO (International Federation of Gynaecology and Obstetrics) system — a clinical and imaging-based staging system used worldwide. Stage at diagnosis is the most important predictor of treatment outcome.
| FIGO Stage | Cancer Extent | Spread | 5-Year Survival | Primary Treatment |
|---|---|---|---|---|
| Stage IA | Microscopic, confined to cervix | No lymph node involvement | 95–100% | Cone biopsy or simple hysterectomy; trachelectomy if fertility desired |
| Stage IB1 | Visible tumour ≤4cm, confined to cervix | No lymph node involvement | 80–90% | Radical hysterectomy or chemoradiation; trachelectomy for selected patients |
| Stage IB2–IIB | Tumour >4cm or spread to parametrium | No pelvic wall involvement | 60–75% | Concurrent chemoradiation + brachytherapy |
| Stage IIIA–IIIB | Spread to lower vagina or pelvic wall | Possible lymph node involvement | 35–55% | Concurrent chemoradiation + brachytherapy (higher dose) |
| Stage IVA | Invasion of bladder or rectum | Local organ invasion | 20–35% | Chemoradiation + brachytherapy; surgery in selected cases |
| Stage IVB | Distant metastases | Liver, lungs, distant nodes | 10–20% | Chemotherapy + bevacizumab; immunotherapy for eligible patients |
Note: 5-year survival estimates are for squamous cell carcinoma and adenocarcinoma of the cervix treated at specialist oncology centres. Individual outcomes depend on tumour characteristics, response to treatment, and overall health.
Outcomes That Matter
Cervical Cancer 1-Year Survival* — CION vs National Average
When specialist oncology care, brachytherapy access, and tumour board review are part of the treatment plan, survival outcomes improve significantly versus the national average.
83.3%
CION Cancer Clinics67.3%
National average*1-year survival for cervical cancer at specialist oncology centres. National figures: ICMR / National Cancer Registry Programme (NCRP).
Cervical Cancer Treatment at CION Cancer Clinics
The right treatment for cervical cancer depends on the stage, the woman's age, and whether preserving the ability to have children is a priority. Every case at CION is reviewed by our multidisciplinary team — gynaecologic surgical oncology, radiation oncology, and medical oncology together — before any treatment plan is finalised.
Surgery for Early-Stage Cervical Cancer
Stage IA2–IB1
Radical Hysterectomy
Surgical removal of the uterus, cervix, upper vagina, and surrounding tissue for women who do not wish to preserve fertility. Pelvic lymph nodes are removed at the same time to check for spread. CION performs radical hysterectomy via minimally invasive (laparoscopic or robotic) approaches for appropriate cases — smaller incisions, less blood loss, and a faster return to normal activities than open surgery.
Stage IA1
Cone Biopsy (Conisation)
For the earliest-stage cervical cancers where the cancer is very small and confined to the surface of the cervix, a cone biopsy may be all that is needed. A cone-shaped section of the cervix is removed under anaesthesia, and if the margins are clear, no further surgery is required. This approach preserves the uterus and cervix entirely.
Did You Know? After trachelectomy — surgery that removes the cervix while leaving the uterus in place — many women successfully become pregnant and carry healthy pregnancies. Delivery must be by planned caesarean section since the cervix is no longer present, but the ability to carry a pregnancy is preserved. If you are a young woman with early-stage cervical cancer, ask your oncologist whether trachelectomy is an option for you.
Fertility-Sparing Surgery — Can Young Women with Cervical Cancer Still Have Children?
One of the most important questions for younger women diagnosed with cervical cancer is whether they can still have children after treatment. For carefully selected patients with early-stage disease, the answer is yes — through a specialised operation called a trachelectomy.
A trachelectomy removes the cervix and the upper part of the vagina while leaving the uterus completely intact. A permanent stitch (cervical cerclage) is placed at the bottom of the uterus to help support any future pregnancy. The operation can be performed through the vagina, laparoscopically, or robotically, depending on the patient's anatomy and the surgeon's approach.
Who Is Eligible for Trachelectomy
- Stage IA2 or IB1 cervical cancer
- Tumour 2cm or smaller in its widest dimension
- No involvement of lymph nodes (confirmed by imaging and, in some cases, sentinel node biopsy)
- Strong desire to preserve fertility and ability to commit to close follow-up
After trachelectomy, most women can become pregnant naturally or with assisted reproduction. Because the cervix is no longer present, pregnancies are higher risk and delivery must be by planned caesarean section. Studies show pregnancy rates after trachelectomy are encouraging, and long-term cancer control is equivalent to radical hysterectomy for appropriately selected patients.
If you are a young woman who has been diagnosed with early cervical cancer and have been told you need a hysterectomy, it is worth asking whether trachelectomy is an option for your specific situation. CION's gynaecologic oncology team evaluates all eligible patients for fertility-sparing surgery as part of the standard assessment.
Chemoradiation — the Primary Treatment for Locally Advanced Cervical Cancer
For most women with cervical cancer at Stage IB2 and above — where the tumour is larger or has spread to surrounding tissue — the treatment is not surgery but a combination of radiation therapy and chemotherapy given together, followed by brachytherapy. This is the international standard of care and produces excellent cure rates even for locally advanced disease.
Step 1 — External Beam Radiation to the Pelvis (5 to 6 Weeks)
Radiation is delivered from outside the body to the pelvis — covering the tumour, the cervix, the uterus, and the regional lymph nodes — once daily, 5 days a week, for approximately 5 to 6 weeks. CION uses IMRT (precision radiation technique) which shapes the radiation beam to conform tightly to the target, significantly reducing the dose received by the bladder, bowel, and other pelvic organs.
Step 2 — Concurrent Chemotherapy
At the same time as external radiation, a chemotherapy medicine (cisplatin given as a weekly drip) is administered. It makes cancer cells more sensitive to the radiation, significantly improving cure rates compared to radiation alone. Side effects — mainly fatigue, mild nausea, and temporary changes in bladder and bowel function — are monitored and managed throughout treatment.
Brachytherapy — Internal Radiation That Is Unique to Cervical Cancer Treatment
After the course of external radiation and chemotherapy, patients with locally advanced cervical cancer receive brachytherapy — a form of radiation that is placed inside the body. No local hospital treatment page in Hyderabad currently explains this to patients in plain language, despite it being an essential part of treatment.
Here is what brachytherapy involves: a small applicator — a smooth cylinder about the size of a tampon — is placed inside the vagina, positioned so that it sits right next to the cervix. A radioactive source is then briefly introduced through the applicator, delivering a high concentrated dose of radiation precisely to the tumour and cervix from the inside, while the surrounding organs receive much less radiation than they would from external sources alone.
This combination — external radiation covering the whole pelvis, plus brachytherapy delivering an intense local boost — is more effective than external radiation alone at destroying the tumour, and produces better long-term outcomes. Without brachytherapy, local tumour control rates are significantly lower. This is why brachytherapy is a mandatory component of curative chemoradiation for cervical cancer at specialist oncology centres.
Brachytherapy for cervical cancer is typically given as 4 to 6 sessions over 1 to 2 weeks, at the end of the external radiation course. Each session takes about 30 to 60 minutes. Most patients go home the same day. CION's radiation oncology team uses image-guided brachytherapy planning — with MRI or CT imaging of the applicator in position — to ensure the most precise and effective dose delivery.
Treatment for Advanced and Recurrent Cervical Cancer
For Stage IVB cervical cancer — where the cancer has spread to distant organs — or for cancer that has come back after previous treatment, systemic medicines are the primary approach.
Chemotherapy Combination
The standard first-line treatment — a combination of two intravenous chemotherapy medicines given in cycles every 3 weeks.
Bevacizumab (Targeted Therapy)
A medicine that cuts off tumour blood supply, added to chemotherapy. It works by blocking the blood vessels that cancer needs to grow, and has been shown to improve overall survival when added to standard chemotherapy for advanced cervical cancer.
Pembrolizumab (Immunotherapy)
An immunotherapy medicine that helps the immune system recognise and destroy cancer cells. Approved for cervical cancers expressing a specific marker (PD-L1) — tested from a biopsy sample. For marker-positive tumours, adding pembrolizumab to chemotherapy improves survival. CION tests all eligible advanced cervical cancer patients for this marker at diagnosis.
Multidisciplinary Team Review — Every Case Discussed Before Treatment
Cervical cancer management requires surgical oncology, radiation oncology, and medical oncology to work together from the start. At CION, every cervical cancer case is reviewed by our team before any treatment begins:
- FIGO staging review with MRI and CT findings
- Surgery vs chemoradiation decision for Stage IB1/IB2 — both may be appropriate depending on tumour size, lymph node status, and patient preference
- Trachelectomy eligibility assessed for young women with early-stage disease who wish to preserve fertility
- IMRT planning for external beam radiation — protecting bladder, bowel, and ovaries where possible
- Brachytherapy planning — image-guided insertion planning to ensure optimal dose to tumour
- Immunotherapy marker testing arranged for all advanced cases
- Ovarian transposition — moving the ovaries out of the radiation field before pelvic radiation, to preserve hormonal function in young women where possible
- HPV vaccination advice for younger women and family members
- Psychological support and fertility counselling from the time of diagnosis
- NCCN and ESMO Protocol Adherence — digital coordination across all 7 Hyderabad locations
Why Patients Choose CION for Cervical Cancer Treatment in Hyderabad
Eleven reasons our patients pick CION — across volume, gynaecologic oncology expertise, brachytherapy access, and integrated supportive care.
1,000+ Cancer Cases Treated
7 Locations Across Hyderabad
5-Star NABH Accredited
NCCN & ESMO Protocol Adherence
Multidisciplinary Tumour Board
Fertility Counselling
Psychological & Nutritional Support
Dedicated Second Opinion Service
EMI Facility
4.8 / 5 Google Rating
India's Fastest-Growing Cancer Network
Cervical Cancer Treatment Cost in Hyderabad
Treatment costs depend on the stage, the treatment approach (surgery, chemoradiation, or both), and whether advanced systemic therapy is required.
| Treatment | Approx. Cost (INR) | Notes |
|---|---|---|
| Cone Biopsy / LEEP | ₹30,000 – ₹90,000 | For very early Stage IA1; day procedure |
| Radical Hysterectomy (Laparoscopic) | ₹1,50,000 – ₹4,00,000 | Stage IA2–IB1; laparoscopic; 2–3 day stay |
| Trachelectomy (Fertility-Sparing) | ₹2,00,000 – ₹5,00,000 | Specialist procedure; requires experienced gynaecologic oncologist |
| External Beam Radiation — IMRT (full course) | ₹1,20,000 – ₹2,50,000 | 5–6 weeks; 25–28 fractions |
| Concurrent Cisplatin Chemotherapy (full course) | ₹60,000 – ₹1,50,000 | Weekly drip during radiation; 5–6 cycles |
| Brachytherapy (full course) | ₹50,000 – ₹1,50,000 | 4–6 sessions after external radiation |
| Full Chemoradiation + Brachytherapy | ₹2,50,000 – ₹5,00,000 | Most locally advanced patients need this |
| Chemotherapy + Targeted / Immunotherapy (per cycle) | ₹80,000 – ₹2,50,000 | For Stage IVB or recurrent disease |
| HPV Vaccine (Gardasil 9, full course) | ₹9,000 – ₹16,000 | 3-dose course; prevention not treatment |
Costs are indicative. A personalised cost estimate is provided following your initial oncology consultation at CION.
Financial Support Options
- EMI Facility — flexible instalment-based payment options available for all patients.
- Private Health Insurance — CION works with all major TPAs for cashless hospitalisation.
Cervical Cancer Care Near You — In Hyderabad & Beyond
CION operates 35+ centres across Telangana and Andhra Pradesh. Find your nearest cervical cancer specialist or explore care options in your city.
Cervical Cancer Care in Hyderabad — by Location
Cervical Cancer Care Beyond Hyderabad
Travelling for treatment? We may have a centre right where you are — across Telangana and Andhra Pradesh.
Vizag
Warangal
Karimnagar
Nizamabad
Mahabubnagar
Suryapet
Nalgonda
Sangareddy
Siddipet
Vizianagaram
Srikakulam
Bobbili
Not seeing your city? Call 18002028726 — we'll connect you to the nearest CION centre or arrange a teleconsultation.
Talk to Us
Get a Free Second Opinion on Your Treatment Plan
Particularly valuable if hysterectomy has been recommended and you want to know if fertility-sparing trachelectomy is an option for you.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Frequently Asked Questions
Common questions about cervical cancer treatment in Hyderabad — answered by CION's gynaecologic oncology team.
What are the symptoms of cervical cancer?
Early cervical cancer often has no symptoms — which is why regular screening is so important. When symptoms appear, the most common is abnormal vaginal bleeding: bleeding after sex, spotting between periods, or vaginal bleeding after menopause. Other symptoms include unusual vaginal discharge (watery, bloody, or with an unusual smell), pelvic pain or pain during sex, and pain with urination. Any unusual vaginal bleeding, particularly after sex or after menopause, should be evaluated by a gynaecologist or oncologist as soon as possible.
Is cervical cancer curable?
Yes — cervical cancer is highly curable, particularly when found early. Stage IA has cure rates of 95 to 100%. Stage IB1 achieves 80 to 90% with radical hysterectomy or chemoradiation. Even Stage IIB and IIIB, treated with concurrent chemoradiation and brachytherapy, achieve 5-year survival rates of 35 to 75%. The key is specialist oncology management — particularly access to brachytherapy, which significantly improves outcomes for locally advanced disease compared to external radiation alone.
What causes cervical cancer?
Almost all cervical cancers are caused by persistent infection with high-risk types of HPV (human papillomavirus) — particularly HPV-16 and HPV-18. HPV is a very common virus; most sexually active people carry it at some point without knowing. In most cases, the immune system clears the infection. In some women, it persists and over 10 to 15 years causes the cell changes that develop into cancer. Additional risk factors include smoking, a weakened immune system (such as from HIV), and never having had a Pap smear screening.
Can cervical cancer be prevented?
Yes — cervical cancer is one of the most preventable cancers. HPV vaccination, ideally given before first HPV exposure (ages 9 to 14), eliminates the risk from the two HPV types responsible for approximately 70% of cervical cancers. Regular Pap smear and HPV DNA testing screens for cell changes years before they become cancer — at a stage when a simple outpatient procedure removes them completely. No smoking, maintaining a healthy immune system, and regular cervical screening together make cervical cancer almost entirely preventable with existing tools.
What is brachytherapy for cervical cancer?
Brachytherapy is a form of radiation that is placed inside the body rather than delivered from outside. For cervical cancer, a small smooth applicator is placed inside the vagina at the end of the external radiation course, positioned right next to the cervix. A radioactive source is briefly introduced through the applicator, delivering a high concentrated dose of radiation directly to the tumour from the inside. This gives a far higher dose to the cancer than could be safely delivered from outside the body. Brachytherapy is an essential component of curative treatment for locally advanced cervical cancer and is given as 4 to 6 sessions after external radiation is completed.
Can young women with cervical cancer still have children?
Yes — for carefully selected patients with early-stage cervical cancer (Stage IA2 to IB1 with a tumour 2cm or smaller), a fertility-sparing operation called trachelectomy removes the cervix while leaving the uterus in place. After recovery and appropriate monitoring, many women can become pregnant naturally or with assisted reproduction. Delivery must be by planned caesarean section. Trachelectomy has been shown to provide equivalent long-term cancer control to radical hysterectomy in appropriately selected patients. Ask CION's gynaecologic oncology team whether you are eligible.
What is the survival rate for cervical cancer in India?
Survival depends heavily on stage at diagnosis. Stage IA: 95 to 100%. Stage IB1: 80 to 90%. Stage IB2–IIB: 60 to 75%. Stage III: 35 to 55%. Stage IVA: 20 to 35%. Stage IVB: 10 to 20%. India's overall cervical cancer survival rate is lower than in Western countries primarily because most women are diagnosed at Stage III or IV — due to lack of screening access and low awareness. Women who are screened regularly and diagnosed early have outcomes that match international standards.
What is the difference between a hysterectomy and a trachelectomy?
A hysterectomy removes the entire uterus (and in a radical hysterectomy, also the cervix, upper vagina, and surrounding tissue). After hysterectomy, pregnancy is not possible. A trachelectomy removes only the cervix and upper vagina while leaving the uterus in place. The bottom of the uterus is reattached to the vagina with a permanent stitch. After a trachelectomy, the uterus is intact and many women successfully carry pregnancies. Trachelectomy is only an option for early-stage disease with small tumours — radical hysterectomy is used for larger or more advanced tumours.
What is the cost of cervical cancer treatment in Hyderabad?
Costs vary by stage and treatment. Laparoscopic radical hysterectomy costs ₹1,50,000 to ₹4,00,000. Trachelectomy costs ₹2,00,000 to ₹5,00,000. Full concurrent chemoradiation with brachytherapy costs ₹2,50,000 to ₹5,00,000. Chemotherapy combined with targeted or immunotherapy medicines for advanced disease costs ₹80,000 to ₹2,50,000 per cycle. HPV vaccination (Gardasil 9, full 3-dose course) costs approximately ₹9,000 to ₹16,000. CION provides a personalised cost estimate after your consultation. EMI options are available.
Can I get a second opinion for cervical cancer?
Absolutely — and for cervical cancer, a second opinion is particularly valuable in three situations: if hysterectomy has been recommended for early-stage disease and you want to know whether fertility-sparing trachelectomy is an option; if brachytherapy has not been included in the treatment plan for locally advanced cervical cancer (brachytherapy is an essential component of curative treatment); and if advanced cervical cancer has been offered only standard chemotherapy without any discussion of immunotherapy or marker testing. CION offers a dedicated Second Opinion service.
Disclaimer: This content is intended for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified oncologist for guidance specific to your medical condition. The information on this page is periodically reviewed and updated by CION's medical team in accordance with current clinical guidelines.